Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reprogramming mediated by stem cell fusion.

Dominic J Ambrosi1, Theodore P Rasmussen

  • 1Center for Regenerative Biology, University of Connecticut, Storrs, CT, 06269-4243, USA.

Journal of Cellular and Molecular Medicine
|June 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlations of Long Noncoding RNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism.

Drug metabolism and disposition: the biological fate of chemicals·2024
Same author

Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2024
Same author

Identification and Functional Characterization of Alternative Transcripts of LncRNA HNF1A-AS1 and Their Impacts on Cell Growth, Differentiation, Liver Diseases, and in Response to Drug Induction.

Non-coding RNA·2024
Same author

Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin.

Pharmacological reviews·2023
Same author

Nephrotoxicity of marketed antisense oligonucleotide drugs.

Current opinion in toxicology·2023
Same author

Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies.

ACS pharmacology & translational science·2022
Same journal

Valsartan Reduces Myocardial Ischemia-Reperfusion Injury by Inhibiting Ferritinophagy-Mediated Ferroptosis.

Journal of cellular and molecular medicine·2026
Same journal

Metabolic Dysregulation of FC3 Fibrochondrocytes via MDH2 Promotes Intervertebral Disc Degeneration.

Journal of cellular and molecular medicine·2026
Same journal

PGK1 Drives Glial Glycolytic Reprogramming to Mediate Isoflurane-Induced Cognitive Impairment in Aged Mice.

Journal of cellular and molecular medicine·2026
Same journal

Oxypaeoniflorin Ameliorates Titanium Particle-Stimulated Osteolysis by Targeting Nrf2 to Reprogram Mitochondrial Homeostasis in Osteoclasts.

Journal of cellular and molecular medicine·2026
Same journal

Correction to 'TLR4 Contributes to the Damage of Cartilage and Subchondral Bone in Discectomy-Induced TMJOA Mice'.

Journal of cellular and molecular medicine·2026
Same journal

EXPRESSION OF CONCERN: An Upstream Open Reading Frame Regulates Vasculogenic Mimicry of Glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 Pathway.

Journal of cellular and molecular medicine·2026
See all related articles

Somatic cell reprogramming can be achieved by fusing cells, creating hybrid cells with totipotency. This fusion-mediated reprogramming holds promise for future cell-based therapies.

Area of Science:

  • Reproductive biology
  • Cell biology
  • Developmental biology

Background:

  • Mammalian cloning demonstrates somatic nucleus reprogramming to totipotency via oocyte transfer.
  • Alternative reprogramming strategies involve cell fusion to create hybrids.

Purpose of the Study:

  • To review advances in fusion-mediated reprogramming.
  • To discuss the developmental potential of hybrid cells.
  • To explore the genetic and epigenetic aspects of reprogramming.

Main Methods:

  • Fusion of somatic cells with cells possessing reprogramming activity (e.g., embryonic stem cells).
  • Analysis of hybrid cell developmental potency.
  • Investigation of genetic and epigenetic changes during reprogramming.

Related Experiment Videos

Main Results:

  • Hybrid cells exhibit varying degrees of developmental potency.
  • Reprogramming involves significant genetic and epigenetic modifications.
  • Successful reprogramming via cell fusion has been demonstrated.

Conclusions:

  • Fusion-mediated reprogramming offers an alternative to nuclear transfer for somatic genome reprogramming.
  • This technique has potential applications in regenerative medicine and cell-based therapies.